newsfilter
← Latest News
GlobeNewswire·

Caladrius Biosciences to Present at the BIO CEO & Investor Conference

BASKING RIDGE, N.J., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or rever